Page last updated: 2024-08-26

3,3'-dioctadecylindocarbocyanine and Retinal Diseases

3,3'-dioctadecylindocarbocyanine has been researched along with Retinal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aihara, M; Araie, M; Chen, YN; Murata, H; Numaga, J; Ota, T1
Bartlett, CA; Dunlop, SA; Evill, L; Fitzgerald, M; Harvey, AR; Payne, SC1

Other Studies

2 other study(ies) available for 3,3'-dioctadecylindocarbocyanine and Retinal Diseases

ArticleYear
Imaging mouse retinal ganglion cells and their loss in vivo by a fundus camera in the normal and ischemia-reperfusion model.
    Investigative ophthalmology & visual science, 2008, Volume: 49, Issue:12

    Topics: Animals; Carbocyanines; Cell Count; Disease Models, Animal; Female; Fluorescein Angiography; Fundus Oculi; Gene Expression; Green Fluorescent Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Photography; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells

2008
Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:11

    Topics: Animals; Calcium Channel Blockers; Carbocyanines; Caspase 3; Cell Count; Cell Death; Cell Survival; Female; Fluorescent Antibody Technique, Indirect; Fluorescent Dyes; Neuroprotective Agents; Optic Nerve Injuries; Piperazines; Rats; Retinal Diseases; Retinal Ganglion Cells; Tubulin

2009